HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

64Cu- cyclam- RAFT- cyclo(arginyl- glycyl- aspartyl- phenylalanyl- lysyl)4

a PET probe; structure in first source

Also Known As:

64Cu-cyclam-RAFT-c(-RGDfK-)4; 64Cu-cyclam-RAFT-c(RGDfK)4; 64Cu-cyclam-RAFT-cyclo(Arg-Gly-Asp-Phe-Lys)4

Networked: 4 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - 64Cu-cyclam-RAFT-cyclo(arginyl-glycyl-aspartyl-phenylalanyl-lysyl)4: 4
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - 64Cu-cyclam-RAFT-cyclo(arginyl-glycyl-aspartyl-phenylalanyl-lysyl)4: 4
Inorganic Chemicals: 9
- Coordination Complexes: 576
  - 64Cu-cyclam-RAFT-cyclo(arginyl-glycyl-aspartyl-phenylalanyl-lysyl)4: 4
Organic Chemicals: 133
- Coordination Complexes: 576
  - 64Cu-cyclam-RAFT-cyclo(arginyl-glycyl-aspartyl-phenylalanyl-lysyl)4: 4

Experts

1.	Boturyn, Didier: 4 articles (12/2020 - 05/2011)
2.	Dumy, Pascal: 4 articles (12/2020 - 05/2011)
3.	Jin, Zhao-Hui: 4 articles (12/2020 - 05/2011)
4.	Fujibayashi, Yasuhisa: 3 articles (06/2018 - 05/2011)
5.	Degardin, Mélissa: 2 articles (12/2020 - 06/2018)
6.	Higashi, Tatsuya: 2 articles (12/2020 - 06/2018)
7.	Nagatsu, Kotaro: 2 articles (12/2020 - 06/2018)
8.	Sugyo, Aya: 2 articles (12/2020 - 06/2018)
9.	Tsuji, Atsushi B: 2 articles (12/2020 - 06/2018)
10.	Zhang, Ming-Rong: 2 articles (12/2020 - 06/2018)

Related Diseases

1.	Neoplasms (Cancer) 06/19/2018 - "Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model." 12/01/2012 - "64Cu-cyclam-RAFT-c(-RGDfK-)4 PET enabled clear tumor visualization by targeting the vasculature, and the biodistribution assay indicated high tumor-to-blood and tumor-to-muscle ratios of 31.6 ± 6.3 and 6.7 ± 1.1, respectively, 3 h after probe injection. " 12/01/2012 - "We concluded that 64Cu-cyclam-RAFT-c(-RGDfK-)4 PET can be used for in vivo angiogenesis imaging and monitoring of tumor response to antiangiogenic therapy." 12/01/2012 - "TSU-68 significantly slowed tumor growth and reduced MVD; these findings were consistent with a significant reduction in the tumor 64Cu-cyclam-RAFT-c(-RGDfK-)4 uptake. " 12/01/2012 - "Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c(-RGDfK-)4."
2.	Ovarian Neoplasms (Ovarian Cancer) 12/01/2020 - "Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer."
3.	Neoplasm Metastasis (Metastasis) 12/01/2020 - "Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer."

Related Drugs and Biologics

1.	Integrins
2.	Radiopharmaceuticals
3.	cyclic arginine-glycine-aspartic acid peptide
4.	orantinib (SU6668)
5.	arginyl-glycyl-aspartic acid
6.	Peptides (Polypeptides)
7.	Tyrosine Kinase Inhibitors

Related Therapies and Procedures

1.	Therapeutics